Assenagon Asset Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,761
Closed -$48K 1263
2025
Q2
$48K Sell
13,761
-83,895
-86% -$331K ﹤0.01% 1143
2025
Q1
$359K Buy
+97,656
New +$357K ﹤0.01% 1059
2024
Q4
Sell
-125,974
Closed -$95.7K 1447
2024
Q3
$95.7K Sell
125,974
-9,772
-7% -$12.8K ﹤0.01% 1348
2024
Q2
$244K Buy
135,746
+52,450
+63% +$151K ﹤0.01% 1352
2024
Q1
$396K Sell
83,296
-2,866
-3% -$10.1K ﹤0.01% 1239
2023
Q4
$250K Sell
86,162
-174,476
-67% -$275K ﹤0.01% 1347
2023
Q3
$352K Sell
260,638
-1,200
-0.5% -$2.1K ﹤0.01% 1256
2023
Q2
$563K Hold
261,838
﹤0.01% 1107
2023
Q1
$762K Hold
261,838
﹤0.01% 1123
2022
Q4
$1.8M Hold
261,838
0.01% 846
2022
Q3
$833K Buy
+261,838
New +$952K ﹤0.01% 972
2022
Q2
Sell
-18,800
Closed -$57K 1584
2022
Q1
$57K Buy
+18,800
New +$63.5K ﹤0.01% 1390
2021
Q4
Sell
-87,405
Closed -$573K 1560
2021
Q3
$573K Sell
87,405
-198,459
-69% -$1.9M ﹤0.01% 1036
2021
Q2
$4.58M Buy
+285,864
New +$3.95M 0.02% 504

Other funds holding STIM

Assenagon Asset Management's STIM Position: Q3 2025 in Review

Assenagon Asset Management sold out of Neuronetics (STIM) in Q3 2025, closing a stake of 13,761 shares — an estimated $48K sold.

Assenagon Asset Management first reported a position in STIM in Q2 2021 and held it in 14 quarters. The position peaked at $4.58M in Q2 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q3 2025.

  • Assenagon Asset Management reported no remaining Neuronetics position as of Q3 2025 after selling out during the quarter.
  • Assenagon Asset Management sold 13,761 Neuronetics shares in Q3 2025, an estimated $48K.
  • Assenagon Asset Management first reported a position in Neuronetics in Q2 2021 and held it in 14 quarters.
  • Assenagon Asset Management's Neuronetics position peaked at $4.58M in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q3 2025.

Based on Assenagon Asset Management's 13F filing for Q3 2025, filed 7 Oct 2025.